| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 0 | 0 | 0 | 9.706 | 16.696 | 17.054 | 27.488 | 27.439 |
| Total Income - EUR | - | 0 | 0 | 0 | 0 | 9.706 | 16.722 | 17.056 | 27.509 | 27.450 |
| Total Expenses - EUR | - | 39 | 76 | 0 | 0 | 1.558 | 20.249 | 19.819 | 24.304 | 26.456 |
| Gross Profit/Loss - EUR | - | -39 | -76 | 0 | 0 | 8.147 | -3.528 | -2.762 | 3.205 | 995 |
| Net Profit/Loss - EUR | - | -39 | -76 | 0 | 0 | 7.856 | -3.725 | -3.046 | 2.935 | 559 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Doctor Hazelnut Company S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 77 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 63 | 62 | 43 | 42 | 10.444 | 11.289 | 12.351 | 19.129 | 20.471 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 6.790 | 0 | 0 | 586 | 3.365 |
| Cash | - | 63 | 62 | 43 | 42 | 3.654 | 11.289 | 12.351 | 18.543 | 17.106 |
| Shareholders Funds | - | 6 | -70 | -69 | -67 | 7.790 | 3.893 | 860 | 3.792 | 4.330 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 134 | 131 | 112 | 109 | 2.654 | 7.395 | 11.491 | 15.337 | 16.141 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "125 - 125" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Doctor Hazelnut Company S.r.l.